AAAAAA
Results:
1-17
|
Results: 17
Authors:
Eap, CB
Bondolfi, G
Zullino, D
Savary-Cosendai, L
Powell-Golay, K
Kosel, M
Baumann, P
Citation: Cb. Eap et al., Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers, J CL PSYCH, 21(3), 2001, pp. 330-334
Authors:
Eap, CB
Broly, F
Mino, A
Hammig, R
Deglon, JJ
Uehlinger, C
Meili, D
Chevalley, AF
Bertschy, G
Zullino, D
Kosel, M
Preisig, M
Baumann, P
Citation: Cb. Eap et al., Cytochrome P450 2D6 genotype and methadone steady-state concentrations, J CL PSYCH, 21(2), 2001, pp. 229-234
Authors:
Bart, PA
Rizzardi, PG
Gallant, S
Golay, KP
Baumann, P
Pantaleo, G
Eap, CB
Citation: Pa. Bart et al., Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir, THER DRUG M, 23(5), 2001, pp. 553-555
Authors:
Eap, CB
Bondolfi, G
Zullino, D
Bryois, C
Fuciec, M
Savary, L
Jonzier-Perey, M
Baumann, P
Citation: Cb. Eap et al., Pharmacokinetic drug interaction potential of risperidone with cytochrome P450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test, THER DRUG M, 23(3), 2001, pp. 228-231
Authors:
Zullino, DF
Eap, CB
Voirol, P
Citation: Df. Zullino et al., Ondansetron for tardive dyskinesia, AM J PSYCHI, 158(4), 2001, pp. 657-658
Authors:
Eap, CB
Citation: Cb. Eap, Comment: opiate withdrawal symptoms induced by antiretroviral drugs, ANN PHARMAC, 34(9), 2000, pp. 1077-1078
Authors:
Eap, CB
Citation: Cb. Eap, On the usefulness of therapeutic drug monitoring of methadone, EUR ADDIC R, 6(1), 2000, pp. 31-33
Authors:
Eap, CB
Bourquin, M
Martin, JL
Spagnoli, J
Livoti, S
Powell, K
Baumann, P
Deglon, JJ
Citation: Cb. Eap et al., Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment, DRUG AL DEP, 61(1), 2000, pp. 47-54
Authors:
Marzolini, C
Troillet, N
Telenti, A
Baumann, P
Decosterd, LA
Eap, CB
Citation: C. Marzolini et al., Efavirenz decreases methadone blood concentrations, AIDS, 14(9), 2000, pp. 1291-1292
Authors:
Eap, CB
Bertel-Laubscher, R
Zullino, D
Amey, M
Baumann, P
Citation: Cb. Eap et al., Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: A case report, PHARMACOPS, 33(3), 2000, pp. 112-115
Authors:
Eap, CB
Bender, S
Gastpar, M
Fischer, W
Haarmann, C
Powell, K
Jonzier-Perey, M
Cochard, N
Baumann, P
Citation: Cb. Eap et al., Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19-and CYP3A4/5-phenotyped patients, THER DRUG M, 22(2), 2000, pp. 209-214
Authors:
Leavitt, SB
Shinderman, M
Maxwell, S
Eap, CB
Paris, P
Citation: Sb. Leavitt et al., When "enough" is not enough: New perspectives on optimal methadone maintenance dose, MT SINAI J, 67(5-6), 2000, pp. 404-411
Authors:
Voirol, P
Jonzier-Perey, M
Porchet, F
Reymond, MJ
Janzer, RC
Bouras, C
Strobel, HW
Kosel, M
Eap, CB
Baumann, P
Citation: P. Voirol et al., Cytochrome P-450 activities in human and rat brain microsomes, BRAIN RES, 855(2), 2000, pp. 235-243
Authors:
Fjordside, L
Jeppesen, U
Eap, CB
Powell, K
Baumann, P
Brosen, K
Citation: L. Fjordside et al., The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine, PHARMACOGEN, 9(1), 1999, pp. 55-60
Authors:
Felder, C
Uehlinger, C
Baumann, P
Powell, K
Eap, CB
Citation: C. Felder et al., Oral and intravenous methadone use: some clinical and pharmacokinetic aspects, DRUG AL DEP, 55(1-2), 1999, pp. 137-143
Authors:
Eap, CB
Yasui, N
Kaneko, S
Baumann, P
Powell, K
Otani, K
Citation: Cb. Eap et al., Effects of carbamazepine coadministration on plasma concentrations of the enantiomers of mianserin and of its metabolites, THER DRUG M, 21(2), 1999, pp. 166-170
Authors:
Kosel, M
Eap, CB
Amey, M
Baumann, P
Citation: M. Kosel et al., Analysis of the enantiomers of citalopram and its demethylated metabolitesusing chiral liquid chromatography, J CHROMAT B, 719(1-2), 1998, pp. 234-238
Risultati:
1-17
|